Referred to the Committee on Energy and Commerce, and in addition to the Committees on the Judiciary, and Financial Services, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Summary
The bill establishes a Prescription Drug Price Regulatory Commission that will calculate a yearly “fair price” for each approved medication and require the HHS Secretary to publish and enforce that price. Drug makers must sell at or below the fair price, though temporary waivers of up to 90 days are allowed to keep drugs available. Manufacturers that refuse to comply face penalties, aiming to make medicines more affordable for patients and providers.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when HR 9040 changes status, plus AI-powered summaries and stage predictions.
Sign up free